InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

4D Molecular Therapeutics, Inc.

FDMT Clue Score62
United States Fiscal year ends December CIK 0001650648 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
David Kirn
5 Oct 2026
See Remarks
Sold on a plan
272
$13.61
$3.70K
David Kirn
5 Oct 2026
See Remarks
Sold on a plan
58,061
$12.92
$750.24K
David Kirn
14 Sep 2026
See Remarks
Sold on a plan
58,333
$13.90
$811.00K
David Kirn
4 Aug 2026
See Remarks
Sold on a plan
26,842
$10.23
$274.60K
David Kirn
3 Aug 2026
See Remarks
Sold on a plan
12,415
$10.05
$124.72K
David Kirn
10 Jul 2026
See Remarks
Sold on a plan
442
$12.84
$5.67K
David Kirn
10 Jul 2026
See Remarks
Sold on a plan
15,283
$12.01
$183.56K
David Kirn
9 Jul 2026
See Remarks
Sold on a plan
42,608
$12.87
$548.18K
David Kirn
22 Jun 2026
See Remarks
Sold on a plan
114,746
$10.47
$1.20M
David Kirn
1 Jun 2026
See Remarks
Sold on a plan
1,922
$10.02
$19.26K
Show all 26 transactions →

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 15
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 88,275
History held since 17 Dec 2020